Tet1 activity and function in helper T cells

辅助 T 细胞中的 Tet1 活性和功能

基本信息

批准号：
8754547
负责人：
Amy Susan Weinmann
金额：
$ 18.38万
依托单位：
UNIVERSITY OF ALABAMA AT BIRMINGHAM
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-08-01 至 2016-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8754547
关键词：
Address Area BTB/POZ Domain CD4 Positive T Lymphocytes Cell Lineage Cells Complex Cytosine DNA DNA Modification Process DNA Packaging DNA biosynthesis Data Development Disease Enzymes Epigenetic Process Event Excision Future Gene Expression Gene Expression Regulation Gene Mutation Gene Targeting Genes Genome Genomics Goals Helper-Inducer T-Lymphocyte Hematopoietic Neoplasms High Prevalence Histones Immune Immune response Immune system Influenza Interleukin-2 Knowledge Malignant Neoplasms Mammalian Cell Mediating Memory Methylation Modification Molecular Profiling Mutation Nucleic Acid Regulatory Sequences Organism Pattern Phenotype Play Ploidies Population Process Protein Family Protein translocation Proteins Recruitment Activity Repression Research Research Priority Role Site Specific qualifier value Specificity Structure of germinal center of lymph node T cell differentiation T cell response T memory cell T-Cell Development T-Lymphocyte Testing Therapeutic Intervention Time Tissue-Specific Gene Expression Virus Diseases base cell type cellular development demethylation flexibility histone modification human disease insight leukemia/lymphoma novel programs promoter public health relevance research study response transcription factor vaccination strategy

项目摘要

DESCRIPTION (provided by applicant): The importance of properly establishing and maintaining epigenetic states in cellular development is unmistakable. The critical role for this process is highlighted by the number of mutations in epigenetic modifying proteins that are associated with human diseases, with a particularly high prevalence found in cancers. Similarly in the immune system, the precise coordination of epigenetic events is also required for cellular differentiation, and blood cancers such as leukemia and lymphoma often have mutations that impact the functions of epigenetic-modifying complexes. Recent research efforts have focused on profiling epigenetic modifications to define their cell-type and activation-state specific distribution. There also has been an emphasis on correlating changes in epigenetic patterns with human disease states. However, a major gap in our current knowledge has been defining the events that control the site specific targeting of the enzymatic machinery that regulates epigenetic patterns in unique cellular states. This is a high impact area of research because cell-type and activation-state specific epigenetic patterns cannot be explained without knowledge of the mechanisms that direct epigenetic-modifying complexes to unique sites in different cellular contexts. The focus of this proposal will be on the site-specific genomic targeting and functional activity of the DNA- demethylase Tet1 in helper T cells. Until recently, i was unclear if a cell possessed enzymatic machinery with the potential to actively remove the methyl modification on cytosine bases within the DNA. Some of the first hints that active DNA demethylation occurs in mammalian cells came from studies in T cells examining the IL-2 promoter, where the DNA replication-independent removal of cytosine methylation modifications was experimentally observed. The discovery of the ten-eleven-translocation (TET) protein family provided the first evidence that cytosine methylation could be broken down by a cellular enzyme into a hydroxymethylated state, with the potential to then be successively converted to the unmethylated state. Notably, mutations in TET proteins are found in a number of blood cancers, highlighting the importance of this protein family in immune cell development. In this proposal, we will for the first time define the mechanisms that target Tet1 to specific genomic loci in helpe T cells and its importance in the immune response. These studies will form the basis for understanding the site-specific targeting of Tet1 to loci in helper T cell development and how this impacts cellular transitions as well as the functional potential of the cells during an immune response to viral infection.

描述（由申请人提供）：在细胞发育中正确建立和维持表观遗传状态的重要性是明确无误的。与人类疾病相关的表观遗传修饰蛋白突变的数量凸显了这一过程的关键作用，其中在癌症中发现的患病率特别高。同样，在免疫系统中，细胞分化也需要表观遗传事件的精确协调，白血病和淋巴瘤等血癌通常具有影响表观遗传修饰复合物功能的突变。最近的研究工作集中在分析表观遗传修饰，以定义其细胞类型和激活状态的特定分布。人们还强调将表观遗传模式的变化与人类疾病状态联系起来。然而，我们目前知识中的一个主要差距是定义控制酶机制的位点特异性靶向的事件，该酶机制在独特的细胞状态下调节表观遗传模式。这是一个高影响力的研究领域，因为如果不了解将表观遗传修饰复合物引导到不同细胞环境中独特位点的机制，就无法解释细胞类型和激活状态特定的表观遗传模式。该提案的重点是辅助 T 细胞中 DNA 去甲基化酶 Tet1 的位点特异性基因组靶向和功能活性。直到最近，我还不清楚细胞是否具有酶机制，能够主动去除 DNA 内胞嘧啶碱基上的甲基修饰。哺乳动物细胞中发生主动 DNA 去甲基化的一些初步线索来自于对 T 细胞检查 IL-2 启动子的研究，其中通过实验观察到 DNA 复制独立的胞嘧啶甲基化修饰的去除。 10-11-易位（TET）蛋白家族的发现提供了第一个证据，证明胞嘧啶甲基化可以被细胞酶分解为羟甲基化状态，然后有可能连续转化为非甲基化状态。值得注意的是，在许多血癌中发现了 TET 蛋白的突变，凸显了该蛋白家族在免疫细胞发育中的重要性。在本提案中，我们将首次定义将 Tet1 靶向辅助 T 细胞中特定基因组位点的机制及其在免疫反应中的重要性。这些研究将为了解辅助性 T 细胞发育中 Tet1 对位点的位点特异性靶向以及这如何影响细胞转变以及免疫过程中细胞的功能潜力奠定基础。对病毒感染的反应。